DFX Intelligence
Private Equity Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Transactions / S•••••••
I••••••• Acquires S••••••• to Enhance Pharmacy Services for Clinical Trials
Add-on acquisitionannouncedadd-onannounced Sep 2, 2026Fact
What happened
- Target
- S•••••••
- Platform
- I••••••• G••••add-on basis: I••••••• Acquires S••••••• to Enhance Pharmacy Services for Clinical Trials | I••••••• is held by V•••• S••••• C•••••• P••••••• on its portfolio page; published on V•••• S••••• C•••••• P•••••••'s own news page
- Control
- Control
- Share acquired
- unknown
- Industry
- healthcare / clinic, pharma
- Target location
- NC, US
- Seller kind
- unknown
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
5 named
Buy side
- “I••••••• Acquires S••••••• to Enhance Pharmacy Services for Clinical Trials | I••••••• is held by V•••• S••••• C•••••• P••••••• on its portfolio page; published on V•••• S••••• C•••••• P•••••••'s own news page”
- “I••••••• Acquires S••••••• to Enhance Pharmacy Services for Clinical Trials | I••••••• is held by V•••• S••••• C•••••• P••••••• on its portfolio page; published on V•••• S••••• C•••••• P•••••••'s own news page”
Side not stated
- ““ I am delighted to welcome S••••••• to I••••••• ,” says S••••• F•••••••, CEO of I••••••• G••••.”
- “Having pioneered the original pharmacy card model for clinical trials more than a decade ago, I am extremely proud of what S••••••• has built and the value our cloud-based, digital pharmacy card platform continues to deliver to sponsors, sites, and patients, ” says B•••• H••••, CEO and co-founder of”
- “I••••••• Acquires S••••••• to Enhance Pharmacy Services for Clinical Trials”
Evidence
“I••••••• Acquires S••••••• to Enhance Pharmacy Services for Clinical Trials”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 16, 2026